Abstract
Intestinal transplantation has become the end-point treatment for patients who undergo intestinal failure and do not stand for long-lasting parenteral nutrition. The use of a third drug associated to Tacrolimus and steroids aims to reduce the toxicity of tacrolimus by reducing its dose. Some advantages have been shown on the association of monoclonal anti-bodies. Isquemia and reperfusion …